American Society of Hirudotherapy

Research Briefs

One-page summaries of key hirudotherapy research topics

Last Updated: March 5, 2026Reviewed by: Andrei Dokukin, MD

Last updated: March 14, 2026

These research briefs provide concise overviews of key evidence areas in hirudotherapy. Each brief summarizes the current state of evidence, key studies, and clinical implications. Tier badges indicate the ASH evidence classification: Tier A (FDA-cleared), Tier B (RCT-supported), or Tier C (investigational).

Evidence Methodology

For details on how ASH classifies and evaluates clinical evidence, including the GRADE framework, study design hierarchy, and the 3-tier classification system, see the Evidence Assessment page.

Evidence Assessment →

Full Research Library

Browse the complete collection of research articles, in-depth analyses, and pharmacological reviews in the Science Hub.

Science Hub →

Related Resources

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.